Clinical Trial Update: Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating duloxetine in outpatients with major depressive disorder and pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED